Roberts, Glore & Co’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.16M | Sell |
22,236
-180
| -0.8% | -$10.8K | 0.32% | 73 |
|
|
2025
Q4 | $1.32M | Sell |
22,416
-525
| -2% | -$31.9K | 0.35% | 68 |
|
|
2025
Q3 | $1.28M | Sell |
22,941
-1,361
| -6% | -$72.9K | 0.35% | 69 |
|
|
2025
Q2 | $1.25M | Sell |
24,302
-584
| -2% | -$29.3K | 0.37% | 68 |
|
|
2025
Q1 | $1.46M | Sell |
24,886
-800
| -3% | -$54.2K | 0.44% | 59 |
|
|
2024
Q4 | $1.85M | Sell |
25,686
-234
| -0.9% | -$17.2K | 0.55% | 50 |
|
|
2024
Q3 | $2.07M | Sell |
25,920
-160
| -0.6% | -$12K | 0.6% | 41 |
|
|
2024
Q2 | $1.87M | Hold |
26,080
| – | – | 0.56% | 47 |
|
|
2024
Q1 | $1.84M | Sell |
26,080
-28
| -0.1% | -$2K | 0.55% | 49 |
|
|
2023
Q4 | $2.01M | Hold |
26,108
| – | – | 0.63% | 44 |
|
|
2023
Q3 | $1.78M | Sell |
26,108
-18
| -0.1% | -$1.42K | 0.59% | 45 |
|
|
2023
Q2 | $2.13M | Sell |
26,126
-388
| -1% | -$31.2K | 0.68% | 36 |
|
|
2023
Q1 | $1.97M | Sell |
26,514
-98
| -0.4% | -$7.55K | 0.66% | 39 |
|
|
2022
Q4 | $2.21M | Sell |
26,612
-1,580
| -6% | -$125K | 0.77% | 36 |
|
|
2022
Q3 | $2M | Sell |
28,192
-232
| -0.8% | -$20K | 0.72% | 39 |
|
|
2022
Q2 | $2.46M | Sell |
28,424
-228
| -0.8% | -$21.4K | 0.82% | 33 |
|
|
2022
Q1 | $3.1M | Sell |
28,652
-216
| -0.7% | -$22.3K | 0.89% | 28 |
|
|
2021
Q4 | $3.73M | Sell |
28,868
-276
| -0.9% | -$33.8K | 0.98% | 23 |
|
|
2021
Q3 | $3.53M | Sell |
29,144
-2,400
| -8% | -$292K | 1.07% | 24 |
|
|
2021
Q2 | $3.55M | Sell |
31,544
-400
| -1% | -$42.1K | 1.06% | 24 |
|
|
2021
Q1 | $3.05M | Sell |
31,944
-228
| -0.7% | -$20.8K | 0.95% | 28 |
|
|
2020
Q4 | $2.55M | Sell |
32,172
-20
| -0.1% | -$1.45K | 0.83% | 33 |
|
|
2020
Q3 | $1.99M | Buy |
+32,192
| New | +$2.09M | 0.71% | 40 |
|
|
2019
Q4 | – | Sell |
-23,404
| Closed | -$1.15M | – | 181 |
|
|
2019
Q3 | $1.15M | Sell |
23,404
-224
| -0.9% | -$11.2K | 0.7% | 45 |
|
|
2019
Q2 | $1.23M | Sell |
23,628
-440
| -2% | -$22.2K | 0.75% | 41 |
|
|
2019
Q1 | $1.2M | Sell |
24,068
-200
| -0.8% | -$9K | 0.75% | 41 |
|
|
2018
Q4 | $878K | Sell |
24,268
-492
| -2% | -$20.6K | 0.62% | 49 |
|
|
2018
Q3 | $1.26M | Sell |
24,760
-5,280
| -18% | -$234K | 0.72% | 41 |
|
|
2018
Q2 | $1.11M | Sell |
30,040
-744
| -2% | -$28.4K | 0.68% | 44 |
|
|
2018
Q1 | $1.16M | Sell |
30,784
-1,400
| -4% | -$49.5K | 0.72% | 41 |
|
|
2017
Q4 | $1.04M | Sell |
32,184
-144
| -0.4% | -$4.58K | 0.64% | 48 |
|
|
2017
Q3 | $977K | Sell |
32,328
-1,000
| -3% | -$29.7K | 0.63% | 48 |
|
|
2017
Q2 | $979K | Buy |
33,328
+100
| +0.3% | +$2.73K | 0.65% | 47 |
|
|
2017
Q1 | $844K | Sell |
33,228
-1,840
| -5% | -$47.5K | 0.58% | 54 |
|
|
2016
Q4 | $902K | Hold |
35,068
| – | – | 0.63% | 48 |
|
|
2016
Q3 | $960K | Sell |
35,068
-580
| -2% | -$15.9K | 0.69% | 47 |
|
|
2016
Q2 | $1M | Sell |
35,648
-9,996
| -22% | -$257K | 0.76% | 43 |
|
|
2016
Q1 | $1.08M | Sell |
45,644
-11,600
| -20% | -$255K | 0.82% | 38 |
|
|
2015
Q4 | $1.29M | Sell |
57,244
-444
| -0.8% | -$10.1K | 0.97% | 31 |
|
|
2015
Q3 | $1.33M | Sell |
57,688
-400
| -0.7% | -$10K | 1.04% | 30 |
|
|
2015
Q2 | $1.43M | Sell |
58,088
-1,472
| -2% | -$36.8K | 1% | 33 |
|
|
2015
Q1 | $1.49M | Sell |
59,560
-600
| -1% | -$14.3K | 1.03% | 31 |
|
|
2014
Q4 | $1.39M | Sell |
60,160
-600
| -1% | -$13.7K | 0.93% | 35 |
|
|
2014
Q3 | $1.42M | Sell |
60,760
-1,000
| -2% | -$23.4K | 0.98% | 34 |
|
|
2014
Q2 | $1.43M | Sell |
61,760
-2,880
| -4% | -$63.6K | 0.97% | 35 |
|
|
2014
Q1 | $1.38M | Sell |
64,640
-15,892
| -20% | -$358K | 0.95% | 34 |
|
|
2013
Q4 | $1.91M | Sell |
80,532
-580
| -0.7% | -$12.6K | 1.32% | 22 |
|
|
2013
Q3 | $1.62M | Sell |
81,112
-24,304
| -23% | -$461K | 1.2% | 25 |
|
|
2013
Q2 | $1.82M | Buy |
+105,416
| New | +$1.75M | 1.12% | 27 |
|
Other funds holding TECH
VCM
VPM
MC
Roberts, Glore & Co's TECH Position: Q1 2026 in Review
Roberts, Glore & Co reduced its Bio-Techne (TECH) stake by 0.8% in Q1 2026, selling an estimated $10.8K and leaving 22,236 shares worth $1.16M. The position accounts for 0.32% of the portfolio, ranked #73.
Roberts, Glore & Co first reported a position in TECH in Q2 2013 and has held it in 49 quarters since. The position peaked at $3.73M in Q4 2021. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Roberts, Glore & Co held 22,236 shares of Bio-Techne worth $1.16M as of Q1 2026.
- Roberts, Glore & Co sold 180 Bio-Techne shares in Q1 2026, an estimated $10.8K.
- Bio-Techne made up 0.32% of Roberts, Glore & Co's portfolio in Q1 2026, its #73 holding.
- Roberts, Glore & Co first reported a position in Bio-Techne in Q2 2013 and has held it in 49 quarters since.
- Roberts, Glore & Co's Bio-Techne position peaked at $3.73M in Q4 2021.
- 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Roberts, Glore & Co's 13F filing for Q1 2026, filed 4 May 2026.